Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gaelle Rousseau-Bussac
New PDL1 Inhibitors for Non-Small Cell Lung Cancer: Focus on Pembrolizumab
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Pembrolizumab‐induced Secondary Sclerosing Cholangitis in a Non‐small Cell Lung Cancer Patient
Respirology Case Reports
Pulmonary
Respiratory Medicine
Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)
Open Access Journal of Oncology and Medicine
New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
New Developments in the Management of Non-Small-Cell Lung Cancer, Focus on Rociletinib: What Went Wrong?
OncoTargets and Therapy
Oncology
Pharmacology
Combination of Pembrolizumab and 125I Attenuates the Aggressiveness of Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer
Current Oncology
Oncology
Alectinib and Brigatinib: New Second-Generation ALK Inhibitors for the Treatment of Non–Small Cell Lung Cancer
Journal of the Advanced Practitioner in Oncology
